This is a pretty straight forward trade. The daily Transportation Index ETF $IYT jumped from $173 to $187 in three days. First, this makes it overbought for a swing trade short. Then you note the major trend line price hit today that stretches back to 2015 and the multiple technical indicators screaming overbought. Lastly, add in that this run is factoring in tax reform, which means there will be little further risk even if tax reform gets through (which is likely). This is a solid risk/reward swing trade short. I would like to see a pull back minimally to $168.00.

Read more: Why I Shorted The Transportation ETF $IYT...

Stocks Mentioned: (OTCQB: $GOPH), (NYSE: $ABB), (NASDAQ: $AMZN), (LSE: ALB.L), ( $AAPL), ( $BIDU) 

Point Roberts, WA, Delta BC – November 30, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors updates its stock directory for artificial intelligence and robotics stocks for investors following the sector.

According to a report from Research and Markets, “The artificial intelligence market was valued at US$ 1.36 Bn in 2016 and is expected to grow at a CAGR of 52% during the forecast period from 2017 to 2025.”

The report also notes, “Many international giants are engaged in the development of a variety of technologies which are categorized under the field of artificial intelligence. Technologies such as deep learning, intelligent robots, neuro-linguistic programming and querying method, among others have been aiding in the enhancement of the existing systems to produce maximum output.”

Read more: #AI and #Robotics Stocks Update; Global Artificial Intelligence Market Expected to Grow at a CAGR...

Workday Inc (WDAY:NASDAQ) is a leading provider of enterprise cloud applications for finance and human resources. The stock recently topped out on November 27, 2017 at $116.89 a share. Since that high pivot, the stock has declined sharply. Last night, the company reported earnings and the stock is falling lower today by $2.54 to $104.00 per share. The pattern forming on the weekly chart is what we call an outside reversal pattern. This is usually a very bearish pattern that indicates further downside is possible in the coming weeks. Traders should realize the stock is short-term oversold on the daily chart already, so there could be some minor bounces or positive trading days in the stock. But please note, the weekly reversal pattern that has formed is not a sign of strength. This pattern will generally indicate more weekly chart selling down the road.

Read more: Technical Trade Lesson: Weekly Outside Reversal Pattern

Industry veteran Franco Cerantola brings aerospace, telecommunications and high-tech sector expertise

TORONTO, ON - November 30, 2017 – (Investorideas.com Newswire)  Patriot One Technologies Inc. (TSX.V: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), makers of the award-winning PATSCAN CMR™(Cognitive Microwave Radar) concealed weapons detection system are pleased to announce the appointment of Mr. Franco Cerantola, PMP to the position of Vice President, Product Delivery.

Read this news in full at http://www.investorideas.com/news/2017/defense/11301TSXPAT-VicePresident.asp

Read more: #Defense #Stock News: Patriot One (TSX.V: $PAT.V) (OTCQB: $PTOTF) Appoints Vice President to...

#Stocks Mentioned: Veritas Pharma Inc. (CSE: $VRT.C; OTC: $VRTHF), ( $NEPT), ( $GWPH), ( $AXIM),(OTCQB: $LXRP; CSE: $LXX.C)

Point Roberts, WA, November 29, 2017 – Investorideas.com, a global news source and investor resource covering cannabis and hemp stocks issues a sector news alert on patent news and developments and some of the key players.

Read this news in full and see images at http://www.investorideas.com/news/2017/marijuana/11292CannabisPatents.asp

David Cohen, Ph.D., a patent consultant based in Oakland, California told Investor Ideas, “The US government’s “cannabis is illegal” stance has had little apparent dampening effect on patent activity per se, however it’s likely that the opening of markets by the progressive legalization of cannabis and entry into mainstream medicine will stimulate new levels of activity. The current approximately 1,500 cannabis-related US patent cases can be divided into groups: (1) compositions and preparation methods, (2) characterization of cannabinoids in terms of interaction with human cannabinoid receptors, and (3) treating diseases.”

Read more: #Patents in the #Cannabis Sector; A Growing Trend